Cancer is often associated with chronic inflammation. In order to develop potential anticancer and anti-inflammatory agents a series of 26 diarylidenecyclopentanones (DACPs) Ia–Iv, II, III, and IV were synthesized. Five of the synthesized DACPs are novel (Ih, Ij, Ik, Is, and Iv), derivative Iv was characterized using single-crystal X-ray diffraction study. All the synthesized derivatives were tested
癌症通常与慢性炎症有关。为了开发潜在的抗癌药和抗炎药,合成了26种二芳基亚
环戊酮(
DACP)Ia-Iv,II,III和IV。合成的
DACP中有五个是新颖的(Ih,Ij,Ik,Is和Iv),使用单晶X射线衍射研究表征了衍
生物Iv。测试所有合成的衍
生物的抗炎和细胞毒性。复合是通过抑制
PGE 2(
前列腺素E 2)的产生,发现其具有最高的抗炎活性(93.67%)。观察到三个
DACP s(Io,It和Iu)具有很高的细胞毒性,对HeLa的IC 50值分别为8.73±0.06 µM(Io),12.55±0.31 µM(It)和11.47±0.15 µM(Iu)细胞。使用这三个
DACP进行了进一步的染色和细胞周期分析,以了解其作用机理。观察到G 0 / G 1相是细胞经历凋亡的最长相。